Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Noncompetitive AMPA receptor antagonist emerges as development candidate for stroke, epilepsy, etc.

July 5, 1999

Novel noncompetitive AMPA antagonist presented at European Congress of Pharmacology

July 5, 1999

NCC-1048 is a novel neuronal calcium channel blocker with potential in cerebral ischemia

July 5, 1999

Russian scientists test GVS-111 in preclinical assays

July 5, 1999

P&U studies compounds that intervene in the kynurenine metabolic pathway

July 5, 1999

Neuroprotectants in early development at Pharmacia & Upjohn

July 5, 1999

FDA grants orphan drug designation for Ceresine in traumatic brain injury

July 5, 1999

Gene that causes familial British dementia discovered

July 5, 1999

Selective inhibitors of neuronal NOS prepared and tested at Chugai

July 2, 1999

Active Biotech commences phase I trial of MS treatment ahead of schedule

July 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026